Stay updated on MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety

Sign up to get notified when there's something new on the MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety page.
Latest website image capture
Clouds background image

Latest updates to the MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The clinical trial record for the tildrakizumab study in moderate-to-severe plaque psoriasis is now displayed, with its study design, participant criteria, outcome measures, and publication history.
    Difference
    50%
    Check dated 2026-11-08T01:48:03.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T20:59:04.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    An NIH-wide banner announces a transition from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T22:36:48.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The site revision label in the footer changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T22:51:07.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T22:34:34.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the study details. This change blocks access to the trial record and reduces visibility of the page's core content for that study.
    Difference
    19%
    Check dated 2026-09-19T22:22:11.000Z thumbnail image

Stay in the know with updates to MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety

Enter your email address, and we'll notify you when there's something new on the MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety page.